What is Immunovant Inc (IMVT) stock price today?

Immunovant Inc (IMVT) currently trades at $28.94 per share. The stock has a market capitalization of $5.54B and a P/E ratio of —x.

Is IMVT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Immunovant Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is 3.15.

Is Immunovant Inc financially healthy?

Immunovant Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of 3.15 places it in the safe zone.

IMVT

Immunovant Inc

NASDAQ: IMVT · HEALTHCARE · BIOTECHNOLOGY

$28.94

+6.32% today

Updated 2026-05-08

Market cap

$5.54B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.67

Dividend yield

—

52W range

$14 – $30

Volume

1.4M

Market cap

$5.54B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.67

Dividend yield

—

52W range

$14 – $30

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

3.2

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →194 stocks currently score above 75

Price targets

Analyst target

$40.29

+39.22%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy11 Buy5 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 3.15 — safe zone

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-92.33M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-156.73M	$-210.96M	$-259.34M	$-413.84M	$-110.64M
EPS	—	—	—	—	$-2.67
Free cash flow	$-106.37M	$-188.39M	$-214.59M	$-376.63M	$-92.33M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMVT	$5.54B	23	4.3	3.0	5.0	6.8	—	Avoid
LLY	$869.41B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$535.63B	59	4.7	9.0	3.3	6.0	-37.47%	Buy
ABBV	$358.55B	63	4.0	8.0	4.0	5.0	-19.74%	Buy
UNH	$335.78B	54	5.3	5.5	7.3	4.8	+40.60%	Buy
AZN	$286.68B	62	6.0	8.5	5.3	5.0	+6.60%	Buy

Smart narrative

Immunovant Inc trades at $28.94. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 3.15, it sits in the safe zone.

Frequently asked questions

What is Immunovant Inc's stock price?

Immunovant Inc (IMVT) trades at $28.94.

Is Immunovant Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Immunovant Inc (IMVT)?

The analyst target price is $40.29, representing +39.2% upside from the current price of $28.94.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

3.15 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

immunovant.com

Quick metrics

P/S ratio—

ROE-69.40%

Beta0.70

50D MA$26.20

200D MA$22.41

Shares out0.20B

Float0.08B

Short ratio—

Avg volume1.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

IMVT vs LLY →IMVT vs JNJ →IMVT vs ABBV →Stock screener →